XML 150 R113.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Assets at Amortized Cost-Securities - Summary of Reconciliation of Expected Loss to Financial Assets at Amortized Cost - Securities, Segregated by Stages (Detail) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) R$ 84 R$ 93
Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 0 1
Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 48 56
Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 44 44
Corporate debt securities [member] | Eurobonds and others [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 1 9
Corporate debt securities [member] | Other [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 3 3
Chile [member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss 1  
Expected loss   1
Korea [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss 4  
Expected loss   4
Spain [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss 3  
Expected loss   3
Mexico [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss 6  
Expected loss   6
Stage 1 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (185) (198)
Gains / (Losses) 188 (113)
Purchases (147) (172)
Settlements 70 311
Transfer to Stage 2   21
Cure from Stage 3   (34)
Expected loss (74) (185)
Stage 1 [member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (14)  
Gains / (Losses) 37 8
Purchases (36) (34)
Settlements 6 12
Expected loss (7) (14)
Stage 1 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (127) (146)
Gains / (Losses) 144 (129)
Purchases (111) (138)
Settlements 64 299
Transfer to Stage 2   21
Cure from Stage 3   (34)
Expected loss (30) (127)
Stage 1 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (23) (9)
Gains / (Losses) 39 15
Purchases (24) (44)
Settlements 3 15
Expected loss (5) (23)
Stage 1 [member] | Corporate debt securities [member] | Bank deposit certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 1  
Purchases (10)  
Settlements 8  
Expected loss (1)  
Stage 1 [member] | Corporate debt securities [member] | Real estate receivables certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (8) (2)
Gains / (Losses) 6 (10)
Purchases   (9)
Settlements 1 13
Expected loss (1) (8)
Stage 1 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (78) (131)
Gains / (Losses) 74 (124)
Purchases (52) (60)
Settlements 38 250
Transfer to Stage 2   21
Cure from Stage 3   (34)
Expected loss (18) (78)
Stage 1 [member] | Corporate debt securities [member] | Eurobonds and others [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (1) (1)
Gains / (Losses) 8 (6)
Purchases (20) (2)
Settlements 11 8
Expected loss (2) (1)
Stage 1 [member] | Corporate debt securities [member] | Promissory and commercial notes [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (10) (3)
Gains / (Losses) 10 (7)
Purchases (5) (10)
Settlements 3 10
Expected loss (2) (10)
Stage 1 [member] | Corporate debt securities [member] | Other [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (7)  
Gains / (Losses) 6 3
Purchases   (13)
Settlements   3
Expected loss (1) (7)
Stage 1 [member] | Brazil [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (44) (52)
Gains / (Losses) 7 8
Expected loss (37) (44)
Stage 1 [member] | Chile [member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (1)  
Gains / (Losses) 1 (1)
Expected loss   (1)
Stage 1 [member] | Colombia [member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 4  
Purchases (6) (2)
Settlements 1 2
Expected loss (1)  
Stage 1 [member] | Korea [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (4)  
Gains / (Losses) 7 7
Purchases (3) (14)
Settlements   3
Expected loss   (4)
Stage 1 [member] | Spain [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (3)  
Gains / (Losses) 6  
Purchases (5) (3)
Settlements 1  
Expected loss (1) (3)
Stage 1 [member] | Mexico [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (6)  
Gains / (Losses) 19 2
Purchases (22) (15)
Settlements 4 7
Expected loss (5) (6)
Stage 2 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (53) (58)
Gains / (Losses) 19 (9)
Purchases (20) (67)
Settlements 16 61
Transfer to Stage 1   (21)
Transfer to Stage 3   54
Cure from Stage 3   (13)
Expected loss (38) (53)
Stage 2 [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Transfer to Stage 1 (21)  
Stage 2 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (53) (58)
Gains / (Losses) 19 (9)
Purchases (20) (67)
Settlements 16 61
Transfer to Stage 1   (21)
Transfer to Stage 3   54
Cure from Stage 3   (13)
Expected loss (38) (53)
Stage 2 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2) (5)
Gains / (Losses) 2 (3)
Settlements   5
Transfer to Stage 3   1
Expected loss   (2)
Stage 2 [member] | Corporate debt securities [member] | Real estate receivables certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (4)  
Gains / (Losses)   (4)
Settlements 4  
Expected loss   (4)
Stage 2 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (47) (53)
Gains / (Losses) 17 (1)
Purchases (20) (67)
Settlements 12 55
Transfer to Stage 3   53
Cure from Stage 3   (13)
Expected loss (38) (47)
Stage 2 [member] | Corporate debt securities [member] | Eurobonds and others [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses)   (1)
Settlements   1
Stage 3 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,827) (2,397)
Gains / (Losses) 610 (1,278)
Purchases (51) (238)
Settlements 432 1,093
Transfer to Stage 2   (54)
Cure from Stage 1   34
Cure from Stage 2   13
Expected loss (1,836) (2,827)
Stage 3 [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Transfer to Stage 2   (1)
Stage 3 [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Transfer to Stage 2   (53)
Cure from Stage 1   34
Cure from Stage 2   13
Stage 3 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,827) (2,397)
Gains / (Losses) 610 (1,278)
Purchases (51) (238)
Settlements 432 1,093
Transfer to Stage 2   (54)
Cure from Stage 1   34
Cure from Stage 2   13
Expected loss (1,836) (2,827)
Stage 3 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss   (33)
Gains / (Losses) 6 (7)
Purchases (15) (1)
Settlements   42
Expected loss (9)  
Stage 3 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,827) (2,348)
Gains / (Losses) 604 (1,287)
Purchases (36) (207)
Settlements 432 1,021
Expected loss R$ (1,827) (2,827)
Stage 3 [member] | Corporate debt securities [member] | Other [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss   (16)
Gains / (Losses)   16
Purchases   (30)
Settlements   R$ 30